Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Year range
1.
Chinese Journal of Pharmacology and Toxicology ; (6): 299-299, 2018.
Article in Chinese | WPRIM | ID: wpr-705321

ABSTRACT

OBJECTIVE The eradication of cancer stem cells(CSCs)is signifcant for cancer therapy and prevention.METHODS In this study,we evaluated WM130,a novel derivative of matrine,for its effect on CSCs using human hepatocellular carcinoma(HCC)cell lines,their sphere cells,and sorted EpCAM+cells. RESULTS We revealed that WM130 could not only inhibit proliferation and colony formation of HCC cells, but also suppress the expression of some stemness-related genes and up-regulate some mature hepatocyte marker genes, indicating a promotion of differentiation from CSCs to hepatocytes. WM130 also suppressed the proliferation of doxorubicin-resistant hepatoma cells, and markedly reduced the cells with CSC biomarker EpCAM.Moreover,WM130 suppressed HCC spheres,not only primary spheres but also subsequent spheres,indicating an inhibitory effect on self-renewal capability of CSCs.Interestingly,WM130 exhibiteda remarkable inhibitory preference on HCC spheres and EpCAM+cells rather than their parental HCC cells and EpCAM- cells respectively. In vivo, WM130 inhibited HCC xenograft growth, decreased the number of sphere-forming cells, and remarkably decreased the levels of EpCAM mRNA and protein in tumor xenografts. Better inhibitory effect was achieved by WM130 in combination with doxorubicin.Further mechanism study revealed that WM130 inhibited AKT/GSK3β/β-catenin signaling pathway. CONCLUSION Collectively, our results suggest that WM130 remark-ably inhibits hepatic CSCs, and this effect may via the down-regulation of the AKT/GSK3β/β-catenin pathway.These findings provide a strong rationale for the use of WM130 as a novel drug candidate in HCC therapy.

2.
Chinese Medical Journal ; (24): 1678-1684, 2007.
Article in English | WPRIM | ID: wpr-255527

ABSTRACT

<p><b>BACKGROUND</b>Immunotherapy is emerging as a promising cure for cancer. However, a severe problem in this area is the immune tolerance to tumor cells and tumor-associated antigens, as evidenced by the ability of cancer to escape immune surveillance. To overcome this problem this work examined the potential of improving the antigenicity of myeloma by metabolic engineering of its cell surface carbohydrate antigens (i.e., glycoengineering) and presentation of the modified tumor antigens by dendritic cells (DCs) to generate cytotoxic T-lymphocytes (CTLs).</p><p><b>METHODS</b>CD138+ myeloma cells were isolated from 11 multipe myeloma (MM) patients by the immunomagnetic bead method. The MM cells were treated with N-propionyl-D-mannosamine (ManNPr), a synthetic analog of N-acetyl-D-mannosamine (ManNAc), the natural biosynthetic precursor of N-acetyl sialic acid (NeuNAc), to express unnatural N-propionylated sialoglycans. The glycoengineered cells were then induced to apoptosis, and the apoptotic products were added to cultured functional DCs that could present the unnatural carbohydrate antigens to autologous T-lymphocytes.</p><p><b>RESULTS</b>It was found that the resultant DCs could activate CD4+ and CD8+ T-lymphocytes, resulting in increased expression of T cell surface markers, including CD8CD28 and CD4CD29. Moreover, upon stimulation by glycoengineered MM cells, these DC-activated T-lymphocytes could release significantly higher levels of IFN-gamma (P < 0.05). Lactate dehydrogenase (LDH) assays further showed that the stimulated T-lymphocytes were cytotoxic to glycoengineered MM cells.</p><p><b>CONCLUSIONS</b>This work demonstrated that glycoengineered myeloma cells were highly antigenic and the CTLs induced by the DCs loaded with the unnatural myeloma antigens were specifically cytotoxic to the glycoengineered myeloma. This may provide a new strategy for overcoming the problem of immune tolerance for the development of effective immunotherapies for MM.</p>


Subject(s)
Humans , Antigens, Tumor-Associated, Carbohydrate , Allergy and Immunology , Cytotoxicity, Immunologic , Dendritic Cells , Allergy and Immunology , Immunophenotyping , Immunotherapy , Interferon-gamma , Multiple Myeloma , Allergy and Immunology , Pathology , Therapeutics , T-Lymphocytes , Allergy and Immunology
3.
China Journal of Chinese Materia Medica ; (24): 639-640, 2004.
Article in Chinese | WPRIM | ID: wpr-272837

ABSTRACT

<p><b>OBJECTIVE</b>To identify and analyse the different species, same species in different regions and confusion species.</p><p><b>METHOD</b>Near-infrared diffuse reflectance spectrometry was used.</p><p><b>RESULT</b>Clustering analysis showed that clustering relations were far among different Gryllotalpa species and close among the same species from different regions, and there were close relations among the same species from near regions and between Teleogryllus emmus and G. orientalis.</p><p><b>CONCLUSION</b>Near-infrared diffuse reflectance spectrometry method can be used in classification and identification of Gryllotalpa.</p>


Subject(s)
Animals , Cluster Analysis , Drug Contamination , Gryllidae , Chemistry , Classification , Materia Medica , Chemistry , Classification , Pharmacognosy , Species Specificity , Spectroscopy, Near-Infrared
SELECTION OF CITATIONS
SEARCH DETAIL